Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Filings indexed 1,098 across all filing types
Latest filing 2024-05-10 Regulatory Filings
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
ESOP/ESOS/ESPS
Regulatory Filings
2024-05-10 English
Record Date
Regulatory Filings
2024-05-10 English
Dividend
Regulatory Filings
2024-05-10 English
Outcome of Board Meeting
Regulatory Filings
2024-05-10 English
Financial Result Updates
Regulatory Filings
2024-05-10 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an invitation and intimation for a conference call scheduled to discuss the Q4 & FY24 financial and operating performance of Dr. Lal PathLabs Limited. It references the upcoming earnings announcement but does not contain any actual financial data or results. The document is primarily a notice about the conference call event, including details on how to join and the participants. It does not include a transcript or detailed financial report. Therefore, it is not an Earnings Release (ER) or Call Transcript (CT), but rather an announcement related to a conference call. Given the content and length (5836 characters), it fits best as a Regulatory Filing (RNS) because it is a regulatory announcement of an event (conference call) without substantive financial data or transcript. Hence, the classification is Regulatory Filings (RNS) with high confidence.
2024-05-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.